We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Metabolic Incentives to Cooperate Controlled by Bacterial Quorum Sensing

By LabMedica International staff writers
Posted on 24 Oct 2012
Scientists have found that bacterial quorum sensing controls when and which cells in a given population will release “public goods” into their environment, and does so in a way that is at least partly achieved by specific metabolic advantage “incentives” for the individual cells. More...


Quorum sensing (the form of intercellular bacterial communication that enables individual cells to recognize and react to the cell population density of their surrounding community) is a key regulator of the production and release of “public goods” - extracellular products that can be used by any community member. The quorum sensing system is also involved in controlling expression of a few “private goods” - intracellular products not available to other cells. In this study published in the October 12, 2012, issue of the journal Science, the opportunistic lung pathogen Pseudomonas aeruginosa was studied under various metabolic conditions that changed the metabolic cost/benefit balance of producing “public goods” and thereby the competitive balance between “cooperator” cells and “cheater” cells; “cheater” cells being quorum sensing mutants that no longer produce “public goods” in response to increasing population density.

The scientists, from the University of Washington School of Medicine (Seattle, WA), found that quorum sensing–controlled expression of certain intracellular “private goods” can put a metabolic constraint on “cheater” cells and prevent a population collapse. When the researchers manipulated the environment so that the cost of cell cooperation was high and so induced destabilization of cooperation, the “cheater” cells were found to overtake the cooperating producer cells until the population collapsed. The scientists were also able to manipulate environmental conditions to restrict the “cheater” population growth and stabilize quorum sensing (population density) dependent cooperation, thereby providing the “public goods” required to maintain the population and prevent collapse of the community.

Metabolic constraint of social “cheating” provides an explanation for “private goods” regulation by a cooperative system and has general implications for population biology, infection control, and stabilization of quorum-sensing circuits in synthetic biology. The findings also provide additional indication of the potential for developing antibiotic-independent approaches to manage infections. In the future, conditions may be manipulated in order to cause cell populations of dangerous pathogens to collapse - "Perhaps, one day, we'll be able to manipulate infections so that bacterial cooperation is destabilized and infections are resolved," said Dr. Peter Greenberg, UW professor of microbiology and principal author of the study. "We've also gained new insights into how cell cooperation can be stably maintained in biology. It is much more straightforward to study sociality in bacteria than in animals. The payoffs may be in understanding what drives cooperation and conflict in general, and in developing strategies for infection control,” added Prof. Greenberg.

Related Links:

University of Washington School of Medicine



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.